SLXNW

Silexion Therapeutics Ltd. SLXNW

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SLXNW VRPX VINC DRMA PIII FOXO REVB ACON PPBT AKTX
6M -42.24 % -92.47 % -75.47 % 244.94 % -38.94 % -99.97 % -62.93 % -15.75 % -69.98 % -78.19 %
YTD 12.75 % -99.78 % -99.72 % 56.83 % -69.86 % -100.00 % -97.27 % -95.34 % -84.83 % -79.09 %
1Y 13.37 % -99.76 % -99.67 % 77.24 % -61.16 % -100.00 % -94.08 % -94.77 % -81.18 % -73.37 %
3Y -83.35 % -99.99 % -99.93 % -95.01 % -96.29 % -100.00 % -99.99 % -99.99 % -97.80 % -97.19 %
5Y -83.35 % -100.00 % -100.00 % -99.82 % -99.22 % -100.00 % -100.00 % -100.00 % -99.15 % -99.33 %
10Y -83.35 % -100.00 % -99.99 % -99.82 % -99.22 % -100.00 % -100.00 % -100.00 % -99.90 % -99.92 %
From the beginning -83.35 % -100.00 % -99.99 % -99.82 % -99.22 % -100.00 % -100.00 % -100.00 % -99.89 % -99.92 %

Dividend